Navigation Links
Equity Capital Management H1N1 Vaccines and Hard to Treat Diseases (HTDS)

LONDON, Sept. 21 /PRNewswire-FirstCall/ - Equity Capital Management (ECM) has completed a preliminary review of the HTDS business model. ECM is providing an informative report to all HTDS followers at the following link

Equity Capital Management PLC, (ECM) believes that in the current economic climate there are distinct opportunities to purchase under-performing asset-rich businesses ECM business model is to target such under performing companies. ECM believes HTDS is a good target for the acquisition because it is an under-performing and undervalued company, with a great potential. ECM has not been paid in cash or stock for this report on HTDS. ECM may invoice the company for a voluntary cash payment should its report prove to be of assistance to the company.

The entire report will be posted on ECM web site:

The report may also be available on under the "FILING TAB" with the sub heading "Management Discussion and Analysis" or this direct link


ECM is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Please read our report for complete risks and disclosures.


SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Johnson & Johnson and Elan Corporation plc Announce Closing of Transaction Related to Alzheimers Immunotherapy Program and Equity Investment
2. Abaxis, Inc. to Present at the ThinkEquity Sixth Annual Growth Conference
3. Omnicell to Present at Think Equitys 6th Annual Growth Conference
4. Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders Equity
5. MassMutual Analysis: Whole Life Insurance Can Help Supply Retirement Income, Preserve Equity Portfolios During Bear Markets
6. Fountain Healthy Aging Inc Announces $5,000,000 Equity Line Of Credit Investment Secured
7. Smart Ideas at the Intersection of Transportation, Health, and Equity
8. Riverside Partners Completes Growth Equity Investment in Vocollect, the Leader in Voice Solutions for Supply-Chain and Healthcare Workforce Management
9. Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimers Immunotherapy Program and Equity Investment
10. Beacon Equity Researches: Sanofi-Aventis, Amazon, Yahoo, Johnson & Johnson, Novavax and NexMed
11. Lumenis Completes $15 Million Equity Financing From New and Existing Investors
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag ... exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage in ... immediately. , “We are pleased to announce our expanded distribution agreement with ...
(Date:11/30/2015)... , ... November 30, 2015 , ... An inventor from ... in the womb. "My last baby had high blood pressure due to loud noises," ... to protect their babies from noise pollution as well as radio waves and microwaves." ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its inception, ... in independent living, assisted living and all other retirement options. Support for issues ... and research remains a top priority. , So it’s no surprise that ...
(Date:11/30/2015)... ... 30, 2015 , ... Sikka Software announced today that they are showcasing the ... to make complex business decisions by providing the tools and information they need to ... with 10 procedures customized by zip code. , The Sikka Software Ecosystem includes ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... the assets of DataTrade Solutions Inc., a Healthcare IT consulting, development and support ... the programming and technical experience available within DataTrade to extend the services currently ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... NEW YORK , November 27, 2015 ... health system is set to go online. The potential ... and processes is vast and far from fully exploited ... access to patient health records, either via mobile tablet ... ) --> ) ...
(Date:11/27/2015)... PHILADELPHIA , Nov. 27, 2015  Lannett ... that it has completed the acquisition of Kremers ... pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A. ... --> Lannett has acquired KU from UCB ... to certain adjustments, including a customary working capital ...
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
Breaking Medicine Technology: